Study suggests ADHD drugs may affect male puberty

by Deborah Braconnier report

(Medical Xpress) -- A new study released this week in the Proceedings of the National Academy of Science reveals that the medication methylphenidate, best known as Ritalin, may delay puberty in males. The researchers caution that this study was performed in monkeys and more research needs to be done before it can determine possible effects on humans.

Ritalin is a common medication prescribed to millions of children diagnosed with , or ADHD. This a commonly diagnosed behavioral disorder in children. It is more common in boys and affects some 3 to 5 percent of school-aged children and causes symptoms such as over activity and inattentiveness.

The study was conducted on young under 5 years old. The monkeys were divided into groups with one receiving a low dose of methylphenidate, similar to the dose a human ADHD patient would receive, and the other group receiving a high dose, or 10 times what is used in humans. A separate control group was given only the material that the drug was dissolved in for the other monkeys but not the drug itself. These doses were administered over a 40-month time frame. The study was designed to evaluate possible toxic effects of the drug, such as , so the effects they discovered were surprising.

The researchers, including Dr. Donald Mattison from the National Institute of Child Health and Human Development, discovered that testicular descent was significantly postponed in the monkeys that received the high dose of and lower blood testosterone levels and testicular volume were present in both sets of monkeys. The effects were not permanent and by the time the monkeys reached the age of 5, they were at similar stages of puberty compared to untreated monkeys.

Mattison cautions that it is too early to assume there may be . This is a single study and more work needs to be done to see if it is repeatable. He warns that parents should speak with their child’s physician before making any changes to their medications and physicians should consider the possible effects of puberty when prescribing the medication.

More information: Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate, Published online before print September 19, 2011, doi: 10.1073/pnas.1102187108

Abstract
Juvenile male rhesus monkeys treated with methylphenidate hydrochloride (MPH) to evaluate genetic and behavioral toxicity were observed after 14 mo of treatment to have delayed pubertal progression with impaired testicular descent and reduced testicular volume. Further evaluation of animals dosed orally twice a day with (i) 0.5 mL/kg of vehicle (n = 10), (ii) 0.15 mg/kg of MPH increased to 2.5 mg/kg (low dose, n = 10), or (iii) 1.5 mg/kg of MPH increased to 12.5 mg/kg (high dose, n = 10) for a total of 40 mo revealed that testicular volume was significantly reduced (P < 0.05) at months 15 to 19 and month 27. Testicular descent was significantly delayed (P < 0.05) in the high-dose group. Significantly lower serum testosterone levels were detected in both the low- (P = 0.0017) and high-dose (P = 0.0011) animals through month 33 of treatment. Although serum inhibin B levels were increased overall in low-dose animals (P = 0.0328), differences between groups disappeared by the end of the study. Our findings indicate that MPH administration, beginning before puberty, and which produced clinically relevant blood levels of the drug, impaired pubertal testicular development until ∼5 y of age. It was not possible to resolve whether MPH delayed the initiation of the onset of puberty or reduced the early tempo of the developmental process. Regardless, deficits in testicular volume and hormone secretion disappeared over the 40-mo observation period, suggesting that the impact of MPH on puberty is not permanent.

add to favorites email to friend print save as pdf

Related Stories

Pediatric Ritalin may affect young brains

Jul 18, 2007

U.S. medical researchers have discovered use of the attention deficit hyperactivity disorder drug Ritalin by young children might affect their brains.

ADHD medications do not cause genetic damage in children

Nov 19, 2008

In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to ...

Adult ADHD linked with dopamine levels

Aug 09, 2007

Adults with attention-deficit/hyperactivity disorder have a reduced response to the drug Ritalin, U.S. government scientists have found.

Recommended for you

No link seen between oxytocin-assisted labor and ADHD

Feb 09, 2015

(HealthDay)—Mothers who get an extra boost during labor with the medication oxytocin don't face a higher risk of having a child with attention-deficit/hyperactivity disorder (ADHD), a new study says.

Study looks to tap strengths of ADHD students

Feb 04, 2015

People with attention deficit hyperactivity disorder (ADHD), some studies suggest, are more creative and more willing to take risks. Those traits are exactly what the field of engineering needs, say a team ...

Foreign parents resist ADHD treatment for offspring

Feb 02, 2015

Children diagnosed with attention deficient hyperactivity disorder (ADHD) whose parents were born in non-Western countries are less likely to be treated with stimulant medication compared with their Western ...

Common pesticide may increase risk of ADHD

Jan 29, 2015

A commonly used pesticide may alter the development of the brain's dopamine system—responsible for emotional expression and cognitive function – and increase the risk of attention deficit hyperactivity ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.